Adjustment for continuous confounders: an example of how to prevent residual confounding

Rolf H H Groenwold; Olaf H Klungel; Douglas G Altman; Yolanda van der Graaf; Arno W Hoes; Karel G M Moons; PROTECT WP2 (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium, Work Programme 2 [Framework for pharmacoepidemiology studies]); Tjeerd van Staa

doi:10.1503/cmaj.120592

Adjustment for continuous confounders: an example of how to prevent residual confounding

Rolf H H Groenwold, Olaf H Klungel, Douglas G Altman, Yolanda van der Graaf, Arno W Hoes, Karel G M Moons, PROTECT WP2 (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium, Work Programme 2 [Framework for pharmacoepidemiology studies]), Tjeerd van Staa

Pharmacoepidemiology and Clinical Pharmacology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	401-406
Number of pages	6
Journal	Canadian Medical Association Journal
Volume	185
Issue number	5
DOIs	https://doi.org/10.1503/cmaj.120592
Publication status	Published - 2013

Keywords

Aged
Aged, 80 and over
Bias (Epidemiology)
Confidence Intervals
Confounding Factors (Epidemiology)
Epidemiologic Studies
Female
Humans
Influenza Vaccines
Influenza, Human
Male
Mortality
Netherlands
Odds Ratio
Risk Assessment

Access to Document

10.1503/cmaj.120592

http://www.cmaj.ca/content/185/5/401.long

Cite this

Groenwold, R. H. H., Klungel, O. H., Altman, D. G., van der Graaf, Y., Hoes, A. W., Moons, K. G. M., PROTECT WP2 (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium, Work Programme 2 [Framework for pharmacoepidemiology studies]), & van Staa, T. (2013). Adjustment for continuous confounders: an example of how to prevent residual confounding. Canadian Medical Association Journal, 185(5), 401-406. https://doi.org/10.1503/cmaj.120592

@article{6a76d5aa5f454dcdab29c18a64be382c,

title = "Adjustment for continuous confounders: an example of how to prevent residual confounding",

keywords = "Aged, Aged, 80 and over, Bias (Epidemiology), Confidence Intervals, Confounding Factors (Epidemiology), Epidemiologic Studies, Female, Humans, Influenza Vaccines, Influenza, Human, Male, Mortality, Netherlands, Odds Ratio, Risk Assessment",

author = "Groenwold, {Rolf H H} and Klungel, {Olaf H} and Altman, {Douglas G} and {van der Graaf}, Yolanda and Hoes, {Arno W} and Moons, {Karel G M} and {PROTECT WP2 (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium, Work Programme 2 [Framework for pharmacoepidemiology studies])} and {van Staa}, Tjeerd",

year = "2013",

doi = "10.1503/cmaj.120592",

language = "English",

volume = "185",

pages = "401--406",

journal = "Canadian Medical Association Journal",

issn = "0820-3946",

publisher = "Canadian Medical Association",

number = "5",

}

Groenwold, RHH, Klungel, OH, Altman, DG, van der Graaf, Y, Hoes, AW, Moons, KGM, PROTECT WP2 (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium, Work Programme 2 [Framework for pharmacoepidemiology studies]) & van Staa, T 2013, 'Adjustment for continuous confounders: an example of how to prevent residual confounding', Canadian Medical Association Journal, vol. 185, no. 5, pp. 401-406. https://doi.org/10.1503/cmaj.120592

TY - JOUR

T1 - Adjustment for continuous confounders

T2 - an example of how to prevent residual confounding

AU - Groenwold, Rolf H H

AU - Klungel, Olaf H

AU - Altman, Douglas G

AU - van der Graaf, Yolanda

AU - Hoes, Arno W

AU - Moons, Karel G M

AU - PROTECT WP2 (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium, Work Programme 2 [Framework for pharmacoepidemiology studies])

AU - van Staa, Tjeerd

PY - 2013

Y1 - 2013

KW - Aged

KW - Aged, 80 and over

KW - Bias (Epidemiology)

KW - Confidence Intervals

KW - Confounding Factors (Epidemiology)

KW - Epidemiologic Studies

KW - Female

KW - Humans

KW - Influenza Vaccines

KW - Influenza, Human

KW - Male

KW - Mortality

KW - Netherlands

KW - Odds Ratio

KW - Risk Assessment

U2 - 10.1503/cmaj.120592

DO - 10.1503/cmaj.120592

M3 - Article

C2 - 23401401

SN - 0820-3946

VL - 185

SP - 401

EP - 406

JO - Canadian Medical Association Journal

JF - Canadian Medical Association Journal

IS - 5

ER -